Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > BLP25

BLP25 : Biomira : Liposomal protein vaccine

BLP25 Liposomal Vaccine Phase IIB Trial - Questions & Answers
Manufacturer's explanation of encouraging early results from the randomized Phase IIB trial of BLP25 liposomal vaccine in patients with advanced lung cancer. [12/04]

BLP25 Liposomal Vaccine for Lung Cancer (Biomira)
Explains how the BLP25 vaccine works and discusses the status of clinical trials in advanced NSCLC patients. Offers a good basic explanation of how cancer vaccines work.

BLP25 - Recent MEDLINE Abstracts (PubMed)


Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor